Hints and tips:
Showing results for JOHNSON & JOHNSON CONSUMER, INC. f/k/a JOHNSON & JOHNSON CONSUMER COMPANIES, INC
...Ogilvy, which has previously worked with a host of pharma groups including Pfizer and Johnson & Johnson, is launching a business that offers vetted influencers to talk about illnesses and possible solutions...
...Companies’ environmental and social goals had become politicised, he said, but “quality companies are deeply invested in this and if I walk out of this office and I take a 25-year-old associate that has...
...Johnson & Johnson has struck a deal to buy medical device maker Shockwave Medical for $13.1bn, as the healthcare giant puts cash to work from the spin-off of its consumer health arm to pursue acquisitions...
...[These stocks] tend to do better in a falling interest rate environment. Financials, consumer staples and energy are favoured in value strategies,” he said....
...I’m Claer Barrett, the FT’s consumer editor and presenter of our Money Clinic podcast....
...Johnson & Johnson is a very valuable company, notwithstanding its efforts to convince US federal judges of the contrary....
...However F/m argues that the funds, like all ETFs, are largely off limits to investors saving for their retirement in 401(k) pension plans, a key market for bonds....
...The streaming service is betting that screening three live programmes a week will allow it to capture the large and loyal fan base for a show that helped launch the careers of Dwayne “The Rock” Johnson,...
...Pessina, who owns almost 17 per cent of the company, credited her with navigating the company through the pandemic, overseeing its vaccine rollout and improving its “consumer-facing capabilities”....
...” on a previously resilient section of consumers....
...Mattel’s earnings, of $27mn or 8 cents a share, exceeded Wall Street forecasts of a 2 cent loss but the company kept its full-year outlook unchanged....
...That is a near-$600bn disagreement about one of the most scrutinised companies on the planet....
...Shares of Kenvue, the consumer arm of healthcare giant Johnson & Johnson, jumped on their first day of trading after an upsized initial public offering that marked the biggest US listing in almost 18 months...
...Johnson & Johnson, one of the world’s largest healthcare companies, is facing thousands of lawsuits from people alleging they got cancer from using one of their oldest products: talc-based baby powder....
...Its more confident outlook than the one Target offered suggested it could gain market share at a time when US consumers were becoming “more and more stretched”, Tarlowe said....
...The company is eager to resolve the uncertainty regarding the talc claims before it spins off its consumer health division in coming months....
...And if Netflix does ever decide to sign a deal with a proper sports league, the company will have already cut its teeth on the technical aspects of live streaming matches....
...Johnson & Johnson’s newly formed consumer business has been targeted by claims that its talcum powder can cause cancer, days before it attempts to complete the largest US initial public offering in almost...
...It’s a head-scratcher,” Johnson added....
...In 2020, Pfizer spun off its generics business Upjohn, combining it with Mylan to form Viatris, while Johnson & Johnson, GSK, Pfizer and Novartis have all shed their consumer health businesses selling over-the-counter...
...This month’s offerings include more tech stocks than earlier in the year, when the market was dominated by the $4.3bn spin-off of Kenvue, the consumer brands arm of Johnson & Johnson, which chose NYSE....
...Key economic and company reports Here is a more complete list of what to expect in terms of company reports and economic data this week....
...WWE, a family business for decades until this year’s deal with Endeavor, has produced stars including Hulk Hogan and Dwayne “The Rock” Johnson....
...“Prohibition doesn’t work,” he said, arguing that regulation could “move the consumer down the continuum of harm versus forcing [smokers] to . . . a black market”....
...Additional reporting by Andrew Edgecliffe-Johnson...
International Edition